Potentiation of adipogenesis and insulinomimetic effects of a novel vanadium complex (N′-[(E)-(5-bromo-2-oxophenyl) methylidene]-4-methoxybenzohydrazide)oxido- (1,10-phenanthroline)vanadium(IV)in 3T3-L1 cells

Authors

DOI:

https://doi.org/10.5604/01.3001.0013.1048

Keywords:

vanadium complexes, phosphatases inhibition, adipocytes, adipogenesis, glucose utilisation

Abstract

The latest results in action of vanadium compounds show important influence on adipogenesis processes and adipocytes function. Based on previously screening tests in cellular models the novel vanadium complex (N'-[(E)-(5-bromo-2-oxophenyl)methylidene]-4-methoxybenzohydrazide)oxido(1,10-phenanthroline)vanadium(IV) was selected for this study. This complex shown potent inhibition ability of tyrosine phosphatases and differences in the degree of inhibition particular phosphatases was observed. Significantly increasing of intracellular lipid accumulation and proliferative effect on 3T3-L1 preadipocytes confirmed the ability of this complex to enhancement of adipogenesis. The insulinomimetic activity of the tested complex was also demonstrated in fully differentiated 3T3-L1 adipocytes, in which glucose utilization was potentiated. Presented results support the thesis that vanadium complexes show promising possibilities for opportunities of new therapeutic strategies for the treatment of type 2 diabetes involved adipocytes.

Downloads

Download data is not yet available.

Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006; 14;444(7121):847-853.   Google Scholar

Simha V, Garg A. Lipodystrophy: lessons in lipid and energy metabolism. Curr Opin Lipidol. 2006; 17(2):162-169.   Google Scholar

Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012; 308(11):1150-1159   Google Scholar

Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab. 2009; 20(3):107-114.   Google Scholar

Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006; 4(4):263-273.   Google Scholar

Rosen, ED, Spiegelman, BM. Molecular regulation of adipogenesis. Annual Review of Cell Biology, 2000; 16, 145-171.   Google Scholar

Mota de Sá P, Richard AJ, Hang H, Stephens JM. Transcriptional Regulation of Adipogenesis. Compr Physiol. 2017; (2):635-674.   Google Scholar

Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab. 2009; 20(3):107-114.   Google Scholar

Chaudhary S, Dube A, Kothari V, Sachan N, Upasani CD. NS-1: a novel partial peroxisome proliferator-activated receptor γ agonist to improve insulin sensitivity and metabolic profile. Eur J Pharmacol. 2012; 684(1-3):154-160.   Google Scholar

Mayer P, Haas B, Celner J, Enzmann H, Pfeifer A. Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes. Diabetes Obes Metab. 2011; 13(9):791-799.   Google Scholar

Haas B, Schlinkert P, Mayer P, Eckstein N. Targeting adipose tissue. Diabetol Metab Syndr. 2012; 4(1):43.   Google Scholar

Dubyak GR, Kleinzeller A. The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor. J Biol Chem. 1980; 255(11):5306-5312.   Google Scholar

Goldstein BJ. Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. Receptor. 1993; 3(1):1-15.   Google Scholar

Bae KH, Kim WK, Lee SC. Involvement of protein tyrosine phosphatases in adipogenesis: new anti-obesity targets? BMB Rep. 2012; 45(12):700-706.   Google Scholar

Irving E, Stoker AW. Vanadium Compounds as PTP Inhibitors. Molecules. 2017; 22(12): E2269.   Google Scholar

Green H, Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell. 1974; 3(2):127-133.   Google Scholar

Hiromura M, Nakayama A, Adachi Y, Doi M, Sakurai H. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor. J Biol Inorg Chem. 2007; 12(8):1275-1287.   Google Scholar

Zuo YQ, Liu WP, Niu YF, Tian CF, Xie MJ, Chen XZ, Li L. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. J Pharm Pharmacol. 2008; 60(10):1335-1340.   Google Scholar

Liu JC, Yu Y, Wang G, Wang K, Yang XG. Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt. Metallomics. 2013; 5(7):813-820.   Google Scholar

Seale AP, de Jesus LA, Park MC, Kim YS. Vanadium and insulin increase adiponectin production in 3T3-L1 adipocytes. Pharmacol Res. 2006; 54(1):30-38.   Google Scholar

Halevas E, Tsave O, Yavropoulou MP, Hatzidimitriou A, Yovos JG, Psycharis V, Gabriel C, Salifoglou A. Design, synthesis and characterization of novel binary V(V)-Schiff base materials linked with insulin-mimetic vanadium-induced differentiation of 3T3-L1 fibroblasts to adipocytes. Structure-function correlations at the molecular level. J Inorg Biochem. 2015; 147:99-115.   Google Scholar

Zhang L, Huang Y, Liu F, Zhang F, Ding W. Vanadium(IV)-chlorodipicolinate inhibits 3T3-L1 preadipocyte adipogenesis by activating LKB1/AMPK signaling pathway. J Inorg Biochem. 2016; 162:1-8.   Google Scholar

Kazek G, Głuch-Lutwin M, Mordyl B, Menaszek E, Szklarzewicz J, Gryboś R, PapieżM. Cell-based Screening For Identification Of The Novel Vanadium Complexes with Multidirectional Activity Relative To The Cells And The Mechanisms Associated With Metabolic Disorders. Sci. Tech., Innov. 2019; 4(1):47-54.   Google Scholar

Zabierowski P, Szklarzewicz J, Gryboś R, Modryl B, Nitek W. Assemblies of salen-type oxidovanadium(IV) complexes: substituent effects and in vitro protein tyrosine phosphatase inhibition. Dalton Trans. 2014; 43(45):17044-17053.   Google Scholar

Welte S, Baringhaus KH, Schmider W, Müller G, Petry S, Tennagels N. 6,8-Difluoro-4-methylumbiliferyl phosphate:a fluorogenic substrate for protein tyrosine phosphatases. Anal Biochem. 2005; 338(1):32-38.   Google Scholar

Poulos SP, Dodson MV, Hausman GJ. Cell line models for differentiation: preadipocytes and adipocytes. Exp Biol Med. (Maywood). 2010; 235(10):1185-1193.   Google Scholar

Green H, Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 1975; 5(1):19-27.   Google Scholar

Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C. Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem. 2009; 103(4):554-558.   Google Scholar

Smith U, Kahn BB. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. J Intern Med. 2016; 280(5):465-475.   Google Scholar

Glucose utilisation in 3T3-L1 cells subjected to differentiation to adipocytes after incubation with control compounds (isoproterenol, rosiglitazone and BMOV) and vanadium complex

Downloads

Published

2019-03-14

How to Cite

Kazek, G., Głuch-Lutwin, M., Mordyl, B., Menaszek, E., Szklarzewicz, J., Gryboś, R., & Papież, M. (2019). Potentiation of adipogenesis and insulinomimetic effects of a novel vanadium complex (N′-[(E)-(5-bromo-2-oxophenyl) methylidene]-4-methoxybenzohydrazide)oxido- (1,10-phenanthroline)vanadium(IV)in 3T3-L1 cells. Science, Technology and Innovation, 4(1), 55–62. https://doi.org/10.5604/01.3001.0013.1048

Issue

Section

Original articles

Most read articles by the same author(s)